FRESENIUS MEDICAL CARE-ADR (FMS) Stock Income Statement
NYSE:FMS - New York Stock Exchange, Inc. - US3580291066 - ADR - Currency: USD
| 2024 (2024-12-31) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | 2020 (2020-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| Revenue | 19.34B | 19.45B | 19.40B | 17.62B | 17.86B | |||
| Minority Interest Expense | -202.96M | -233.46M | -220.92M | -249.72M | -271.45M | |||
| Cost Of Goods | 14.58B | 14.53B | 14.50B | 12.85B | 12.32B | |||
| Gross Profit | 4.76B | 4.93B | 4.89B | 4.77B | 5.54B | |||
| Operating Expenses | 3.49B | 3.65B | 3.61B | 2.99B | 3.30B | |||
| Research and Development | 183.49M | 231.97M | 228.62M | 220.78M | 188.75M | |||
| Selling, General, and Administrative Expenses | 3.14B | 3.20B | 3.17B | 2.77B | 3.10B | |||
| Operating Income | 1.27B | 1.28B | 1.29B | 1.78B | 2.24B | |||
| Interest Income/Expense | -223.65M | -250.14M | -262.74M | -198.15M | -252.56M | |||
| Non Recurring Items | 14.66M | 4.84M | 195.38M | -8.63M | -51.92M | |||
| Income Before Taxes | 1.06B | 1.03B | 1.22B | 1.57B | 1.94B | |||
| Income Tax | 316.06M | 300.56M | 324.95M | 352.83M | 500.56M | |||
| Net Income | 537.91M | 499.00M | 673.40M | 969.31M | 1.16B | |||
| EBITDA | 3.01B | 3.03B | 3.13B | 3.40B | 4.03B | |||
| Per Share Data | ||||||||
| EPS Diluted Total Ops | 0.92 | 0.85 | 1.15 | 1.65 | 1.98 | |||
| Non GAAP EPS | 1.63 | 1.28 | 1.55 | 1.73 | 2.32 | |||
| Statistics | ||||||||
| Gross Profit Margin | 24.60% | 25.32% | 25.23% | 27.09% | 31.01% | |||
| Profit Margin | 2.78% | 2.57% | 3.47% | 5.50% | 6.52% | |||
| Operating Profit Margin | 6.55% | 6.57% | 6.63% | 10.10% | 12.55% | |||
All data in EUR